Homburg (Saar) Hauptbahnhof

EQS-News: Pyrum Innovations AG publishes figures for the first half of 2023

Retrieved on: 
Saturday, September 16, 2023

Sales in the first six months amounted to EUR 501 thousand and were thus slightly higher than in the first half of 2022 (EUR 485 thousand).

Key Points: 
  • Sales in the first six months amounted to EUR 501 thousand and were thus slightly higher than in the first half of 2022 (EUR 485 thousand).
  • Own work capitalised amounted to EUR 7,613 thousand (H1 2022: EUR 8,495 thousand) as construction of the plant expansion in Dillingen progressed according to plan.
  • Cash and cash equivalents as of 30 June 2023 amounted to EUR 5,431 thousand (December 31, 2022: EUR 12,519 thousand).
  • Pyrum Innovations AG will offer an English-language webcast for investors, private shareholders and members of the press on the current business development on Monday, 18 September 2023, at 10:00 am (CEST).

Preclinical Study Provides Guidance for Optimizing Safety and Efficacy of Endovascular Hepatic Denervation Devices to Treat Diabetes

Retrieved on: 
Wednesday, January 26, 2022

In order to aid in development of a novel hepatic denervation therapy for diabetes mellitus in particular, we conducted a digital morphometric analysis of the tissue surrounding human common hepatic arteries, providing the basis for the development of dedicated technologies and techniques to organ specific denervation.

Key Points: 
  • In order to aid in development of a novel hepatic denervation therapy for diabetes mellitus in particular, we conducted a digital morphometric analysis of the tissue surrounding human common hepatic arteries, providing the basis for the development of dedicated technologies and techniques to organ specific denervation.
  • To provide guidance for both efficacy and safety, we utilized an approach involving a combination of classical gross anatomy and histopathology with immunostaining and image analysis, said John Keating, DVM, DACVP , co-author and Director of Pathology at CBSET.
  • Our data indicate that the common hepatic artery is not only a rich, but also an accessible target for sympathetic modulation by denervation regardless of sex and diabetic status, with efficacy and safety most optimally balanced within the proximal hepatic artery.
  • This study leveraged our deep experience in preclinical evaluation of denervation therapies and could not have been performed in a timely manner without the digital morphometry techniques we developed in-house.

ReCor Medical Launches the Paradise™ Ultrasound Renal Denervation for the Treatment of Hypertension in Europe

Retrieved on: 
Wednesday, October 6, 2021

ReCor Medical, Inc. (ReCor), a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., announced today that the companys Paradise Ultrasound Renal Denervation System (the Paradise System) is now available for the treatment of uncontrolled hypertension in Germany.

Key Points: 
  • ReCor Medical, Inc. (ReCor), a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., announced today that the companys Paradise Ultrasound Renal Denervation System (the Paradise System) is now available for the treatment of uncontrolled hypertension in Germany.
  • We are pleased to be one of the first hospitals in Europe to offer renal denervation with ultrasound.
  • Paradise ultrasound renal denervation is a device-based, minimally invasive procedure for the treatment of high blood pressure.
  • With its Paradise System ReCor has pioneered the minimally invasive use of ultrasound in renal denervation to treat patients with hypertension.

DGAP-News: publity AG: Commercial property sold in Bad Homburg with Deutsche Bahn as main tenant

Retrieved on: 
Wednesday, March 3, 2021

Frankfurt, 03.03.2021- publity AG (Scale, ISIN DE0006972508, "publity") has successfully sold an office property in Bad Homburg in its position as asset manager.

Key Points: 
  • Frankfurt, 03.03.2021- publity AG (Scale, ISIN DE0006972508, "publity") has successfully sold an office property in Bad Homburg in its position as asset manager.
  • The office building provides a total lettable area of just under 5,200 square metres and is situated in a centrally located commercial area of Bad Homburg, just outside Frankfurt/Main.
  • publity acquired the property in 2017 and has since successfully developed it; the main tenants include Deutsche Bahn and a major air conditioning manufacturer.
  • The office property is in the asset portfolio of GORE German Office Real Estate AG (ISIN DE000A0Z26C8), an indirect subsidiary of publity AG.